Earnings History Data for PTC Therapeutics, Inc. (PTCT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

PTC Therapeutics, Inc.

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	AH		PTCT	PTC Therapeutics, Inc.	3,140	-1.39	-1.54	-1.76	PTC Therapeutics GAAP EPS of -$1.39 beats by $0.13, revenue of $196.78M beats by $24.98M [11/7/2024 4:05 PM]	44.35	1.39 (3.25%)	42.96	0.0 (0.00%)	18.15 - 46.55	828,953	630,000	71,061
PTC Therapeutics GAAP EPS of -$1.39 beats by $0.13, revenue of $196.78M beats by $24.98M [11/7/2024 4:05 PM] JFrog slips as earnings season hops along while pair of semis rebound [11/8/2024 12:05 PM] PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results [2024-11-07 04:01PM] Unlocking Q3 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics [Nov-06-24 09:15AM] PTC Therapeutics Inc (PTCT) Q3 2024: Everything You Need To Know Ahead Of Earnings [Nov-06-24 07:11AM]
08-08-2024	AH		PTCT	PTC Therapeutics, Inc.	2,460	-1.16	1.00	-2.66	PTC Therapeutics reports Q2 results [8/8/2024 4:24 PM]	31.40	-1.05 (-3.24%)	32.45	0.0 (0.00%)	17.53 - 42.14	624,035	570,000	15,941
PTC Therapeutics reports Q2 results [8/8/2024 4:24 PM]
25-04-2024	AH		PTCT	PTC Therapeutics, Inc.	1,950	-1.20	-1.31	-1.88	PTC Therapeutics GAAP EPS of -$1.20 beats by $0.07, revenue of $210.12M beats by $46.3M [4/25/2024 4:52 PM]	28.64	3.15 (12.36%)	25.49	0.0 (0.00%)	17.53 - 59.84	1,310,625	1,080,000	169,398
PTC Therapeutics GAAP EPS of -$1.20 beats by $0.07, revenue of $210.12M beats by $46.3M [4/25/2024 4:52 PM]
29-02-2024	AH		PTCT	PTC Therapeutics, Inc.	2,110	-0.24	0.29	-2.35	PTC Therapeutics GAAP EPS of -$2.06 misses by $2.56, revenue of $307.05M misses by $10.82M [2/29/2024 4:18 PM]	32.00	3.81 (13.52%)	27.10	-1.09 (-3.87%)	17.53 - 59.84	1,749,283	860,000	968
PTC Therapeutics GAAP EPS of -$2.06 misses by $2.56, revenue of $307.05M misses by $10.82M [2/29/2024 4:18 PM]
26-10-2023	AH		PTCT	PTC Therapeutics, Inc.	1,750	-1.76	-0.85	-1.53	PTC Therapeutics GAAP EPS of -$1.76 misses by $0.70, revenue of $196.6M misses by $15.07M [10/26/2023 4:28 PM]	18.50	-5.45 (-22.76%)	19.52	-4.43 (-18.50%)	18.03 - 59.84	4,171,385	1,570,000	223,958
PTC Therapeutics GAAP EPS of -$1.76 misses by $0.70, revenue of $196.6M misses by $15.07M [10/26/2023 4:28 PM] PTC Therapeutics stock slides after Citi downgrades to Sell [10/27/2023 9:08 AM]
03-08-2023	AH		PTCT	PTC Therapeutics, Inc.	3,020	-2.66	-1.58	-2.13	PTC Therapeutics GAAP EPS of -$2.66 misses by $1.04, revenue of $213.8M beats by $7.86M [8/3/2023 4:16 PM]	38.63	-1.69 (-4.19%)	40.32	0.0 (0.00%)	33.25 - 59.84	580,059	810,000	7,218
PTC Therapeutics GAAP EPS of -$2.66 misses by $1.04, revenue of $213.8M beats by $7.86M [8/3/2023 4:16 PM]
27-04-2023	AH	4:00 PM ET (Apr 27)	PTCT	PTC Therapeutics, Inc.	3,780	-1.88	-1.62	-1.78	PTC Therapeutics GAAP EPS of -$1.88 misses by $0.47, revenue of $220.4M beats by $19.92M [4/27/2023 4:05 PM]	55.04	2.40 (4.56%)	52.64	0.0 (0.00%)	25.01 - 55.98	962,691	790,000	21,588
PTC Therapeutics GAAP EPS of -$1.88 misses by $0.47, revenue of $220.4M beats by $19.92M [4/27/2023 4:05 PM]
21-02-2023	AH	4:00 PM ET (Feb 21)	PTCT	PTC Therapeutics, Inc.	3,280	-2.35	-1.96	-2.03	PTC Therapeutics GAAP EPS of -$2.35 misses by $0.78, revenue of $167.41M misses by $15.66M [2/21/2023 4:22 PM]	44.02	-0.70 (-1.57%)	44.72	0.0 (0.00%)	25.01 - 55.58	779,394	500,000	191,376
PTC Therapeutics GAAP EPS of -$2.35 misses by $0.78, revenue of $167.41M misses by $15.66M [2/21/2023 4:22 PM]
27-10-2022	AH	4:00 PM ET (Oct 27)	PTCT	PTC Therapeutics, Inc.	3,190	-1.53	-1.37	-1.89	PTC Therapeutics GAAP EPS of -$1.53 misses by $0.24, revenue of $217.13M beats by $32.21M [10/27/2022 4:30 PM]	38.55	-6.03 (-13.53%)	40.49	-4.10 (-9.19%)	25.01 - 55.58	1,659,761	830,000	7,690
PTC Therapeutics GAAP EPS of -$1.53 misses by $0.24, revenue of $217.13M beats by $32.21M [10/27/2022 4:30 PM] PTC Therapeutics to get up to $1B in funding from Blackstone to support pipeline [10/27/2022 4:40 PM] PTC Therapeutics Provides a Corporate Update and Reports Third Quarter Financial Results [Oct-27-22 04:03PM] PTC Therapeutics Announces Strategic Financing Collaboration with Blackstone with up to $1 Billion in Funding [Oct-27-22 04:01PM]
04-08-2022	AH	4:00 PM ET (Aug 4)	PTCT	PTC Therapeutics, Inc.	3,110	-2.13	-1.66	-1.68	PTC Therapeutics Q2 GAAP EPS misses, revenue beats, FY22 guidance reaffirmed [8/4/2022 4:05 PM]	53.54	4.31 (8.75%)	53.51	-0.03 (-0.06%)	25.01 - 53.72	1,235,048	610,000	534
PTC Therapeutics Q2 GAAP EPS misses, revenue beats, FY22 guidance reaffirmed [8/4/2022 4:05 PM] PTC Therapeutics betas topline expectations, strengthens commercial portfolio [8/5/2022 9:32 AM] PTC Therapeutics Provides a Corporate Update and Reports Second Quarter Financial Results [Aug-04-22 04:01PM]
03-05-2022	AH	4:00 PM ET (May 3)	PTCT	PTC Therapeutics	2,593	-1.78	-1.55	0.00	PTC Therapeutics GAAP EPS of -$1.78 misses by $0.27, revenue of $149M beats by $2.1M [5/3/2022 4:05 PM]	36.75	0.99 (2.77%)	35.76	0.0 (0.00%)	32.45 - 45.80	634,907	540,000	8,042
PTC Therapeutics GAAP EPS of -$1.78 misses by $0.27, revenue of $149M beats by $2.1M [5/3/2022 4:05 PM] PTC Therapeutics Provides a Corporate Update and Reports First Quarter Financial Results [May-03-22 04:01PM] PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates [May-03-22 05:45PM]
22-02-2022	AH	4:00 PM ET (Feb 22)	PTCT	PTC Therapeutics, Inc.	2,770	-2.03	-1.79	-1.08	PTC Therapeutics GAAP EPS of -$2.03 misses by $0.34, revenue of $165.2M beats by $4.12M [2/22/2022 4:03 PM]	35.70	-2.75 (-7.15%)	38.45	0.0 (0.00%)	34.85 - 60.61	1,098,180	570,000	10,066
PTC Therapeutics GAAP EPS of -$2.03 misses by $0.34, revenue of $165.2M beats by $4.12M [2/22/2022 4:03 PM] PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-22-22 04:01PM] PTC Therapeutics (PTCT) Reports Q4 Loss, Tops Revenue Estimates [Feb-22-22 05:25PM] PTC Therapeutics to Participate at Upcoming Investor Conferences [Feb-23-22 08:00AM]
28-10-2021	AH	4:00 PM ET (Oct 28)	PTCT	PTC Therapeutics, Inc.	2,530	-1.89	-1.78	-1.03	PTC Therapeutics EPS misses by $0.40, beats on revenue [10/28/2021 4:05 PM]	37.92	1.48 (4.06%)	36.44	0.0 (0.00%)	34.85 - 70.82	523,410	530,000	7,357
PTC Therapeutics EPS misses by $0.40, beats on revenue [10/28/2021 4:05 PM] PTC Therapeutics raises full-year guidance as product revenue soars 40% YoY [10/28/2021 5:43 PM] PTC Therapeutics Provides a Corporate Update and Reports Third Quarter 2021 Financial Results [Oct-28-21 04:00PM] PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates [Oct-28-21 05:15PM] PTC Therapeutics Inc (PTCT) Q3 2021 Earnings Call Transcript [Oct-29-21 12:31AM]
29-07-2021	AH	4:00 PM ET (Jul 29)	PTCT	PTC Therapeutics, Inc.	2,750	-1.68	-1.84	-2.65	PTC Therapeutics EPS beats by $0.13, beats on revenue [7/29/2021 4:09 PM]	38.25	0.01 (0.03%)	38.24	0.0 (0.00%)	37.12 - 70.82	341,570	410,000	6,282
PTC Therapeutics EPS beats by $0.13, beats on revenue [7/29/2021 4:09 PM] Significant Improvements in Survival and Developmental Milestones Demonstrated in Type 1 SMA Patients Treated with Evrysdi [Jul-28-21 05:00PM] PTC Therapeutics Provides a Corporate Update and Reports Second Quarter 2021 Financial Results [Jul-29-21 04:00PM]
04-05-2021	AH	4:00 PM ET (May 4)	PTCT	PTC Therapeutics, Inc.	2,990	-1.83	-1.59	-1.80	PTC Therapeutics EPS misses by $0.28, beats on revenue [5/4/2021 4:03 PM]	40.88	2.41 (6.26%)	40.88	0.0 (0.00%)	38.01 - 70.82	1,168,958	860,000	4,212
PTC Therapeutics EPS misses by $0.28, beats on revenue [5/4/2021 4:03 PM] PTC Therapeutics, Inc. to Host Earnings Call [May-04-21 02:30PM] PTC Therapeutics Provides a Corporate Update and Reports First Quarter 2021 Financial Results [May-04-21 04:01PM] PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates [May-04-21 05:25PM]
25-02-2021	AH	4:00 PM ET (Feb 25)	PTCT	PTC Therapeutics, Inc.	3,910	-1.08	-0.90	-1.15	PTC Therapeutics EPS misses by $0.15, beats on revenue [2/25/2021 4:17 PM]	57.18	1.99 (3.61%)	55.19	0.0 (0.00%)	30.79 - 70.82	789,130	550,005	5,959
PTC Therapeutics EPS misses by $0.15, beats on revenue [2/25/2021 4:17 PM] PTC Therapeutics' Evrysdi wins positive opinion in EU for spinal muscular atrophy [2/26/2021 7:38 AM] PTC Therapeutics (PTCT) Reports Q4 Loss, Tops Revenue Estimates [Feb-25-21 07:10PM] PTC Therapeutics, Inc. to Host Earnings Call [Feb-25-21 02:30PM]
29-10-2020	AH	4:00 PM ET (Oct 29)	PTCT	PTC Therapeutics, Inc.	3,610	-1.03	-1.10	-0.89	PTC Therapeutics EPS misses by $0.97, beats on revenue [10/29/2020 4:12 PM]	52.18	-1.71 (-3.17%)	53.89	0.0 (0.00%)	30.79 - 59.89	606,800	350,460	27,358

05-08-2020	AH	4:00 PM ET (Aug 5)	PTCT	PTC Therapeutics, Inc.	3,040	-2.65	-1.29	-0.66	PTC Therapeutics EPS misses by $1.48, misses on revenue [8/5/2020 4:04 PM]	46.12	-2.85 (-5.82%)	47.00	-1.97 (-4.02%)	30.79 - 59.89	1,676,910	999,973	686,176